# Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial

> **NCT03678675** · PHASE3 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 148 (actual)

## Conditions studied

- Post-operative Pain
- Post-partum Pain
- Cesarean Section Complications

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT03678675
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-30
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03678675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03678675, "Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03678675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*